GPR63 IDG GPCR ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GPR63 IDG GPCR ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GPR63 IDG GPCR ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GPR63 IDG GPCR ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GPR63 IDG GPCR ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

TPTE pseudogene 1

Gene

zinc finger protein 826, pseudogene

Gene

olfactory receptor family 7 subfamily E member 12 pseudogene

Gene

long intergenic non-protein coding RNA 2898

Gene

actin gamma 1 pseudogene 22

Gene

OLA1 pseudogene 2

Gene

NOP56 ribonucleoprotein pseudogene 2

Gene

olfactory receptor family 7 subfamily A member 19 pseudogene

Gene

centromere protein K

Gene

HHLA1 neighbor of OC90

  • Gene

    TPTE pseudogene 1


  • Gene

    zinc finger protein 826, pseudogene


  • Gene

    olfactory receptor family 7 subfamily E member 12 pseudogene


  • Gene

    long intergenic non-protein coding RNA 2898


  • Gene

    actin gamma 1 pseudogene 22


  • Gene

    OLA1 pseudogene 2


  • Gene

    NOP56 ribonucleoprotein pseudogene 2


  • Gene

    olfactory receptor family 7 subfamily A member 19 pseudogene


  • Gene

    centromere protein K


  • Gene

    HHLA1 neighbor of OC90

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.